Skip to main content

Table 4 Lipid control for the treatment

From: Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

  LDL-C control Non-HDL-C control
High-risk (327) Very high-risk (407) High-risk (327) Very high-risk(407)
N (%) 169 (51.7%) 147 (36.1%) 65 (19.9%) 80 (19.7%)
P value 0.5800 < 0.0001 < 0.0001 < 0.0001
Sex
female 44 (44.9%) 49 (36.0%) 16 (16.3%) 24 (17.6%)
male 125 (54.6%) 98 (36.2%) 49 (21.4%) 56 (20.7%)
P value 0.1080 0.9790 0.2930 0.4700
Age (years)
< 50 41 (42.7%) 8 (21.6%) 6 (6.3%) 4 (10.8%)
50–60 52 (46.0%) 39 (30.6%) 23 (20.4%) 18 (14.2%)
> 60 76 (64.4%) 100 (41.2%) 36 (30.5%) 58 (23.9%)
P value 0.0020 0.0220 < 0.0001 0.0300
HbA1c (%)
< 7 62 (68.1%) 48 (41.4%) 35 (38.5%) 30 (25.9%)
7–10 84 (50.6%) 72 (35.0%) 24 (14.5%) 40 (19.4%)
> 10 23 (32.9%) 27 (31.8%) 6 (8.6%) 10 (11.8.%)
P value < 0.0001 0.3310 < 0.0001 0.0450
T2DM duration (years)
< 3 27 (38.0%) 14 (26.9%) 6 (8.5%) 6 (11.5%)
3–10 69 (53.1%) 59 (43.1%) 27 (20.8%) 34 (24.8%)
> 10 73 (57.9%) 74 (33.9%) 32 (25.4%) 40 (18.3%)
P value 0.0250 0.0740 0.0160 0.0950
BMI (kg/m2)
< 24 46 (51.1%) 49 (38.9%) 21 (23.3%) 27 (21.4%)
≥ 24 123 (51.9%) 98 (34.9%) 44 (18.6%) 53 (18.9%)
P value 0.8990 0.4360 0.3350 0.5470
Hypertension
Yes 99 (62.7%) 103 (41.0%) 46 (29.1%) 59 (23.5%)
No 70 (41.4%) 44 (28.2%) 19 (11.2%) 21 (13.5%)
value < 0.0001 0.0090 < 0.0001 0.0130
FLD
Yes 39 (42.9%) 29 (29.6%) 10 (11.0%) 11 (11.2%)
No 130 (55.1%) 118 (38.2%) 55 (23.3%) 69 (22.3%)
P value 0.0470 0.1230 0.0120 0.0160
  1. Values were frequency (percentage). P value was calculated by Chi-square test or Fisher’s exact test